For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 41,110 | |||
| General and administrative | 25,727 | |||
| Total operating expenses | 66,837 | |||
| Interest income | 7,868 | |||
| Other expense | 32 | |||
| Total other income | 7,836 | |||
| Net loss | -59,001 | |||
| Basic EPS | -0.47 | |||
| Diluted EPS | -0.47 | |||
| Basic Average Shares | 126,256,583 | |||
| Diluted Average Shares | 126,256,583 | |||
Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT)